Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. In this episode, Warrick Bishop discusses the use of statin therapy in relation to chemotherapy, specifically its potential to reduce heart failure progression in patients receiving anthracycline treatments for lymphoma. He highlights the STOP CA trial, which aimed to assess the effectiveness of atorvastatin in preventing cardiac dysfunction associated with these cardiotoxic medications. The study involved a double-blind, placebo-controlled design and included patients aged 18 and older who were scheduled for anthracycline therapy. Exclusion criteria ensured a clear focus on participants without prior statin therapy or certain health conditions.